Add BrightSurf on Google Email

The Lancet: Study estimates that, without vaccination against 10 diseases, mortality in children under five would be 45% higher in low-income and middle-income countries

A new study estimates that vaccination against 10 major pathogens will have prevented 69 million deaths in low-income and middle-income countries between 2000 and 2030. Vaccination programs are expected to reduce mortality from these diseases by 72% for those born in 2019, with the greatest impact on children under five.

SourceThe Lancet·JournalThe Lancet·DateJan 28, 2021

Challenges in COVID-19 vaccination

The German National Academy of Sciences Leopoldina hosts an international virtual panel discussion on COVID-19 vaccination challenges. Experts will address issues like equitable global allocation and vaccine effectiveness. The event aims to promote scientific dialogue among the international community.

Offer COVID-19 vaccines to pregnant or breastfeeding people

Pregnant and breastfeeding individuals should be offered COVID-19 vaccines based on ethical principles, considering individual autonomy and risk of severe illness. Although no adverse effects have been observed in vaccinated participants, those at high risk of severe COVID-19 should prioritize vaccination to protect themselves and others.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·DateJan 27, 2021

COVID-19 news from Annals of Internal Medicine

The American College of Physicians and Annals of Internal Medicine hosted a third virtual COVID-19 vaccine forum, discussing the allocation and distribution of available vaccines. Researchers also published an observational study finding that early therapeutic anticoagulation in critically ill patients with COVID-19 did not affect surv...

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·DateJan 25, 2021

Research finds people more likely to follow Covid rules when friends and family do

A recent study published in the British Journal of Psychology found that people are more likely to follow Covid-19 restrictions based on their close circle's behavior rather than their own principles. The researchers discovered that the best predictor of compliance was how much one's close friends and family were following the rules.

SourceUniversity of Nottingham·JournalBritish Journal of Psychology·DateJan 21, 2021

Incentivizing vaccine adherence: could it be the key to achieving herd immunity?

A new Commentary in Preventive Medicine suggests financial incentives could promote high levels of COVID-19 vaccine adherence, crucial for achieving herd immunity. Strong evidence from controlled trials supports the efficacy of incentivizing vaccine adherence, including a 7-fold increase in adherence with modest financial incentives.

COVID-19 news fromAnnals of Internal Medicine

A recent study found that mortality rates decreased among critically ill COVID-19 patients over time. In contrast, experts from NIAID emphasized the importance of using data to encourage vaccine uptake. Meanwhile, a hospital essay describes a Ransomware attack during the pandemic, highlighting the challenges faced by healthcare profess...

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·DateJan 18, 2021

Breakthrough on diarrhea virus opens up for new vaccines

Researchers at Umeå University have made a significant discovery about the diarrhea virus, revealing its ability to survive acidic stomach environments and infect intestines. This understanding could lead to the development of new vaccines, potentially given in edible form, and has implications for tackling diseases like COVID-19.

SourceUmea University·JournalScience Advances·DateJan 11, 2021

Cutting COVID-19 infectious period could prevent millions of cases

A new study suggests that shortening the COVID-19 infectious period by half a day could avert up to 1.4 million cases and over 99,000 hospitalizations, saving $209.5 billion in direct medical costs. Expanding treatment to 75% of infected individuals could avert 29.7 million cases and save $856 billion.

SourcePLOS·JournalPLOS Computational Biology·DateJan 7, 2021

Smart vaccine patch research gets go-ahead

Researchers at Swansea University have received £230,000 to develop a smart vaccine device that delivers the COVID-19 vaccine and measures its efficacy through monitoring biomarkers in the skin. The device uses microneedles for minimally invasive delivery and offers a personalized vaccination approach.

Published data from Moderna COVID-19 vaccine trial show 94.1 percent efficacy

The Moderna COVID-19 vaccine has demonstrated a 94.1 percent efficacy in preventing symptomatic COVID-19 infections and severe illness, according to the results of the ongoing phase 3 clinical trial. The study enrolled over 30,000 participants and found that cases of severe COVID-19 occurred only in those who received the placebo.

SourceBrigham and Women's Hospital·JournalNew England Journal of Medicine·DateDec 30, 2020

UH Mānoa researcher examines why people choose to wear face coverings

A recent national study found that factors such as perceived importance of others, confidence to wear a face covering, and personal importance of use positively associated with intention to wear a face covering. The study suggests that messaging strategies targeting individual intentions and social norms may be more effective than focu...

SourceUniversity of Hawaii at Manoa·JournalAnnals of Behavioral Medicine·DateDec 18, 2020